Flaxseed and Actemra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Flaxseed (flaxseed) and Actemra (tocilizumab). Common drug interactions include pain among females and cerebrovascular accident among males.

The phase IV clinical study analyzes what interactions people have when they take Flaxseed and Actemra. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.

What is Flaxseed?

Flaxseed has active ingredients of flaxseed. It is often used in high blood cholesterol. eHealthMe is studying from 7,137 Flaxseed users. Check the latest studies of Flaxseed.

What is Actemra?

Actemra has active ingredients of tocilizumab. It is often used in rheumatoid arthritis. eHealthMe is studying from 102,759 Actemra users. Check the latest studies of Actemra.



On Jul, 29, 2026

45 people who take Flaxseed and Actemra together, and have interactions are studied.

Flaxseed and Actemra drug interactions.

What are the common drug interactions of Flaxseed and Actemra, by gender? *:

female:

  1. Pain
  2. Pharyngitis (inflammation of the pharynx, causing a sore throat)
  3. Weight increased
  4. Blood pressure diastolic decreased
  5. Dizziness
  6. Nausea (feeling of having an urge to vomit)
  7. Oxygen saturation decreased
  8. Fatigue (feeling of tiredness)
  9. Influenza
  10. Nasopharyngitis (inflammation of the nasopharynx)

male:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  2. Syncope (loss of consciousness with an inability to maintain postural tone)
  3. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  4. Hypoaesthesia (reduced sense of touch or sensation)
  5. Joint range of motion decreased (disease of joint movement)
  6. Joint swelling
  7. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  8. Peripheral swelling
  9. Rectal haemorrhage (bleeding from anus)
  10. Synovial disorder (disease of synovial joint)

What are the common drug interactions of Flaxseed and Actemra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Abdominal discomfort

20-29:

  1. Dizziness
  2. Infusion related reaction
  3. Narcolepsy (brain's inability to regulate sleep-wake cycles normally)

30-39:

  1. Abdominal discomfort
  2. Heart rate increased
  3. Myalgia (muscle pain)
  4. Osteoarthritis (a joint disease caused by cartilage loss in a joint)

40-49:

  1. Injection site pain
  2. Lymphadenopathy (disease or enlargement of lymph nodes)
  3. Oral herpes (viral infection of mouth)
  4. Pain in jaw
  5. Stomatitis (inflammation of mucous membrane of mouth)

50-59:

  1. Oropharyngeal pain
  2. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  3. Poor venous access
  4. Skin warm
  5. Alanine aminotransferase increased
  6. Arthropathy
  7. Dyspepsia (indigestion)
  8. Food allergy
  9. Foot deformity (functional disability of foot)
  10. Hepatic enzyme increased

60+:

  1. Autoimmune thyroiditis (form of thyroiditis associated with an autoimmune disease)
  2. Headache (pain in head)
  3. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  4. Ear congestion
  5. Ear infection
  6. Infusion site pain
  7. Sinusitis (inflammation of sinus)
  8. Stomatitis (inflammation of mucous membrane of mouth)
  9. Syncope (loss of consciousness with an inability to maintain postural tone)
  10. Infection

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 11 people, 24.44%
  2. Primary Immunodeficiency Syndrome: 5 people, 11.11%
  3. Pain: 3 people, 6.67%
  4. High Blood Pressure: 3 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Flaxseed and Actemra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Flaxseed and Actemra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Flaxseed:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Actemra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flaxseed and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Actemra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on flaxseed and tocilizumab (the active ingredients of Flaxseed and Actemra, respectively), and Flaxseed and Actemra (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: